Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Form 8.3 - IMPELLAM GROUP PLC

31 May 2022 14:04

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

Gouda, The Netherlands

1. KEY INFORMATION

(a) Full name of discloser:

Ophorst Van Marwijk Kooy Vermogensbeheer N.V.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

IMPELLAM GROUP PS

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25-05-2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,060,771

 

4,57%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

2,060,771

4,57%

 

 

*OVMK does not not have discretion regarding voting decisions in respect of 1,585,246 shares that are included in the table above.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

1 p ordinary

purchase

 

30.000

4,510000 GBP

 

 

 

 

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

Date of disclosure:

31-05-2022

Contact name:

HENRI DE JONG

Telephone number*:

0031182543677

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220531005645/en/

Copyright Business Wire 2022

Date   Source Headline
24th Sep 20195:47 pmRNSTransaction in Own Shares
19th Sep 20199:39 amRNSTransaction in Own Shares
23rd Aug 20194:46 pmRNSTransaction in Own Shares
8th Aug 20197:00 amRNSTransaction in Own Shares
30th Jul 20197:00 amRNSHalf-year Report
15th Jul 20197:00 amRNSTransaction in Own Shares
9th Jul 20197:00 amRNSAcquisition of AI Powered Staffing Platform
26th Jun 20199:51 amRNSResult of AGM
25th Jun 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jun 20197:00 amRNSTransaction in Own Shares
24th May 20194:50 pmRNSTransaction in Own Shares
8th May 20194:50 pmRNSTransaction in Own Shares
24th Apr 20193:59 pmRNSTransaction in Own Shares
28th Mar 20197:00 amRNSTransaction in Own Shares
21st Mar 20199:00 amRNSPreliminary Results: Correction
21st Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSPreliminary Results - Unaudited
13th Mar 20195:41 pmRNSTransaction in Own Shares
28th Feb 20197:00 amRNSTransaction in Own Shares
20th Feb 20197:00 amRNSDemerger of Carlisle Support Services
14th Feb 20194:21 pmRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20194:29 pmRNSTransaction in Own Shares
21st Dec 20184:18 pmRNSTransaction in Own Shares
5th Dec 20185:02 pmRNSTransaction in Own Shares
14th Nov 20183:36 pmRNSTransaction in Own Shares & Total Voting Rights
13th Nov 20183:04 pmRNSTransaction in Own Shares
8th Nov 20187:00 amRNSTransaction in Own Shares
31st Oct 20187:00 amRNSTransaction in Own Shares
15th Oct 20187:00 amRNSTransaction in Own Shares
8th Oct 20187:00 amRNSTransaction in Own Shares
27th Sep 20185:21 pmRNSTransaction in Own Shares
27th Sep 20184:41 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
27th Sep 20187:00 amRNSDirectorate Change
27th Sep 20187:00 amRNSTrading Statement
22nd Aug 201812:51 pmRNSTransaction in Own Shares
26th Jul 20187:00 amRNSHalf-year Report
21st Jun 201810:05 amRNSResult of AGM
5th Jun 20184:47 pmRNSTransaction in Own Shares and Total Voting Rights
31st May 20187:00 amRNSDirectorate Change
10th May 201812:14 pmRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20186:23 pmRNSHolding(s) in Company
24th Apr 20183:02 pmRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20187:00 amRNSTransaction in Own Shares
20th Mar 20185:17 pmRNSHolding(s) in Company
20th Mar 20185:14 pmRNSDirector/PDMR Shareholding
16th Mar 201810:12 amRNSAnnual Financial Report
8th Mar 20187:00 amRNSPreliminary Results - Unaudited
19th Feb 20183:22 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20184:47 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.